DRKS00025005
Completed
Not Applicable
Prostate-specific Membrane Antigen (PSMA) expression in endometrial cancer
niversitätsklinikum Freiburg Klinik für Frauenheilkunde0 sites61 target enrollmentApril 7, 2021
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- C54
- Sponsor
- niversitätsklinikum Freiburg Klinik für Frauenheilkunde
- Enrollment
- 61
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with histologically verified invasive endometrial carcinoma are included in this study.
Exclusion Criteria
- •\- no declaration of consent
- •\- other oncological disease
- •\- intake of selective oestrogen receptor modulators (SERM, for example tamoxifen)
- •\- after ovarian stimulation therapy
- •\- histologically proved sarcoma, neuroendocrine tumour or mixed tumour
- •\- cytostatic or radiotherapy administered before tissue sampling
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Prostate-specific Membrane Antigen (PSMA) expression in cervical carcinomaC53.9Cervix uteri, unspecifiedDRKS00023289niversitätsklinikum FreiburgKlinik für Frauenheilkunde100
Not yet recruiting
Not Applicable
Prostate-specific membrane antigen (PSMA) expression in ovarian carcinomaC56Malignant neoplasm of ovaryDRKS00023240niversitätsklinikum Freiburg Klinik für Frauenheilkunde100
Recruiting
Phase 2
Prostate-Specific Membrane Antigen (PSMA) Intensity Can be Altered by Androgen and phospho-SrC Obstructiometastatic castration-resistant prostate cancerCancer - ProstateACTRN12621000611820St Vincent's Hospital, Sydney22
Recruiting
Phase 2
Expression of prostate specific membrane antigen (PSMA) in soft tissue sarcomas and urothelial cell carcinomas: implications for tumour-specific molecular imaging and treatment?bladder cancercohort 1: soft tissue cancercohort 2: transitional cell carcinomasoft tissue tumour1002838910004994NL-OMON54064eids Universitair Medisch Centrum120
Not yet recruiting
Phase 1
Emerging digital imaging-guided theranostic therapy for newly diagnosed high risk prostate cancer patients: A feasibility studyProstate CancerCancer - ProstateACTRN12620001358932I-MED Radiology Network5